Skip to main content

Table 4 Factors associated with the development of drug-resistant epilepsy

From: Drug resistant epilepsy and associated factors among children with epilepsies in Tanzania: a cross-sectional study

  

Drug-Resistant Epilepsy

 

Variable

Category

Yes%

No%

P value

Sex

Male

20(15)

113(85)

0.9

Female

15(14.6)

88(85.4%)

Seizure types

1

24(12.8)

164(87.2)

0.077

≥ 2

11(22.9)

37(77.1)

Number of seizures at onset.

< 10

12(7.7)

144(92.3)

< 0.001

≥ 10

23(28.7)

57(71.3)

Developmental delay**

Yes

24(20.3)

94(79.7)

0.017

No

11(9.3)

107(90.7)

Neonatal seizures

Yes

16(25.8)

46(74.2)

0.007

No

19(10.9)

155(89.1)

Epilepsy syndrome

Yes

8(21.1)

30(78.9)

0.23

No

27(13.6)

171(86.4)

History of status epilepticus

Yes

20(27.4)

53(72.6)

< 0.001

No

15(9.2)

148(90.8)

Consanguinity

Yes

1(14.3)

6(85.7)

0.31*

No

34(14.8)

195(85.2)

MRI (N = 141)

Normal

7(12.1)

51(87.9)

0.003

Abnormal

28(33.7)

55(66.3)

EEG (N = 169)

Normal

6(13.3)

39(86.7)

0.281

Abnormal

29(23.3)

95(76.7)

  1. *Fisher’s exact Test
  2. **Children who exhibited delay in at least two of the developmental domains (i.e., gross motor, fine motor, language and communication, social emotional and cognitive)